Trademark: 79314245
Status Date
Tuesday, May 30, 2023
Registration Number
7064213
Registration Date
Tuesday, May 30, 2023
Filing Date
Tuesday, May 11, 2021
Published for Opposition
Tuesday, March 14, 2023
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
May 30, 2023
Notice Of Registration Confirmation Emailed
May 30, 2023
Registered-Principal Register
May 1, 2023
Notification Of Possible Opposition - Processed By Ib
Apr 12, 2023
Notification Of Possible Opposition Sent To Ib
Apr 12, 2023
Notification Of Possible Opposition Created, To Be Sent To Ib
Mar 21, 2023
Notification Processed By Ib
Mar 14, 2023
Official Gazette Publication Confirmation E-Mailed
Mar 14, 2023
Published For Opposition
Feb 22, 2023
Notification Of Possible Opposition Sent To Ib
Feb 22, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Feb 22, 2023
Notification Of Notice Of Publication E-Mailed
Feb 9, 2023
Attorney Review Completed
Feb 6, 2023
Final Disposition Reviewed - No Action Required By Office
Feb 6, 2023
Correction From Ib Entered - Attorney Review Required
May 13, 2022
Reg. Cancelled - Restored To Pendency
May 11, 2022
Assigned To Petition Staff
May 6, 2022
Request To Cancel Inadvertently Issued Registration Received
Feb 10, 2022
Grant Of Protection Created, To Be Sent To Ib
Jan 31, 2022
Teas Section 7 Request Received
Jan 11, 2022
Registered-Principal Register
Nov 14, 2021
Correction Transaction Received From Ib
Oct 26, 2021
Official Gazette Publication Confirmation E-Mailed
Oct 26, 2021
Published For Opposition
Oct 6, 2021
Notification Of Notice Of Publication E-Mailed
Sep 16, 2021
Approved For Pub - Principal Register
Sep 9, 2021
Assigned To Examiner
Jul 13, 2021
Application Filing Receipt Mailed
Jul 9, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Jul 9, 2021
Teas Change Of Correspondence Received
Jul 9, 2021
Teas Change Of Domestic Representatives Address
Jul 9, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 9, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 9, 2021
Teas Change Of Owner Address Received
Jul 7, 2021
New Application Office Supplied Data Entered
Jul 6, 2021
Limitation From Original Application Entered
Jun 25, 2021
Sn Assigned For Sect 66a Subseq Desig From Ib
Trademark Alertz updated from USPTO on 2030-01-24
